North Springs Resources Corp. (NSRS) Stock Price & Analysis
Educational signal · not a buy or sell recommendation · How to read this
Beta 2.06: the stock has moved about 106% more than the S&P 500.
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 18, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerNorth Springs Resources Corp. (NSRS) trades at $0.0001. North Springs Resources Corp. is a development-stage company focused on acquiring and developing mineral resource properties and pharmaceutical/medical technology products. The company is based in Riverview, Florida. Sector: Healthcare.
Price as of · Last analyzed: Mar 18, 2026Analyst Coverage for NSRS: NSRS does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage.
No score published: we hold no usable price for this ticker, and a grade beside a missing price says nothing.
North Springs Resources Corp. (NSRS) Healthcare & Pipeline Overview
North Springs Resources Corp., operating in the specialty and generic drug manufacturing industry, focuses on acquiring and developing mineral resource properties alongside pharmaceutical and medical technology ventures, distinguishing itself through a dual-focus strategy in the competitive healthcare landscape while based in Riverview, Florida.
What Is the Investment Thesis for NSRS?
North Springs Resources Corp. presents a speculative investment opportunity due to its dual focus on mineral resources and pharmaceutical/medical technology. With a market capitalization of $0.00 billion and a negative P/E ratio of -4.41, the company's financial performance raises concerns. The high beta of 2.06 indicates significant volatility. Potential catalysts include successful acquisition and development of new pharmaceutical products or positive developments in its mineral resource properties, though these are highly uncertain. The company's OTC listing and limited information availability contribute to a high-risk profile. Investors should carefully consider the lack of dividends and the company's unproven track record in both sectors before investing.
Based on FMP financials and quantitative analysis
NSRS Key Highlights
Market capitalization of $0.00 billion, indicating a micro-cap company with limited resources and higher risk.
- Negative P/E ratio of -4.41, reflecting current unprofitability.
- Beta of 2.06, suggesting the stock is more volatile than the overall market.
- No dividend yield, meaning investors do not receive income from holding the stock.
- Focus on both mineral resource properties and pharmaceutical/medical technology, indicating a diversified but potentially unfocused business strategy.
Who Are NSRS's Competitors?
NSRS is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| AKAN Akanda Corp. | $1.98 | -10.41% | — | |
| SNOA Sonoma Pharmaceuticals, Inc. | $1.24 | -0.80% | $5.94M | — |
| BFRI Biofrontera Inc. | $1.01 | -2.40% | $13.0M | — |
| COSM COSM | $0.38 | -1.58% | $20.7M | — |
| QNTM Quantum BioPharma Ltd. | $3.44 | +0.44% | $22.0M | — |
| AYTU Aytu BioPharma, Inc. | $2.07 | -0.96% | $22.2M | — |
| TXMD TherapeuticsMD, Inc. | $2.05 | +0.99% | $23.7M | — |
| CPHI CPHI | $0.66 | +0.61% | $26.6M | — |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are NSRS's Key Strengths?
Diversified focus on both mineral resources and healthcare.
- Potential for high growth if successful in either sector.
- Experienced management team (assuming John E. Vivian has relevant experience).
What Are NSRS's Weaknesses?
Small market capitalization and limited resources.
- OTC listing indicates higher risk and lower liquidity.
- Lack of established market presence and track record.
- Dual focus may dilute resources and expertise.
What Are the Key Risks for NSRS?
Financial-distress signal — its Altman Z-Score of -1.30 sits in the distress zone (elevated bankruptcy risk).
- Weak fundamentals — a Piotroski F-Score of 0/9 flags soft profitability, leverage or efficiency.
- Limited access to capital for development projects.
- Intense competition in both mineral resources and healthcare.
- Stringent regulatory requirements in healthcare.
- Fluctuations in commodity prices.
- Economic downturns affecting demand for products and services.
What Are NSRS's Competitive Advantages?
- Limited moat due to small size and lack of established market presence.
- Potential for a niche moat through proprietary technology or unique mineral resource assets.
- Reliance on successful acquisition and development of assets to create a sustainable competitive advantage.
What Does NSRS Do?
North Springs Resources Corp., founded in 2009 and based in Riverview, Florida, initially focused on the evaluation, acquisition, exploration, and development of mineral resource properties. In June 2011, the company changed its name from Aurum Resources Corp. to North Springs Resources Corp., signaling a strategic shift to include the acquisition and development of products and services within the pharmaceutical and medical technology industries. This dual focus reflects an attempt to diversify its portfolio across resource exploration and healthcare sectors. The company's activities in the pharmaceutical and medical technology areas involve identifying and developing various products and services, though specific details on these ventures are not available. North Springs Resources operates within the broader healthcare sector, specifically targeting niche areas within drug manufacturing and medical technology. However, given its small market capitalization and OTC listing, the company faces significant challenges in competing with larger, more established players in these industries. Its success hinges on its ability to effectively identify, acquire, and develop promising assets in both the mineral resource and healthcare domains.
What Products and Services Does NSRS Offer?
- Evaluates mineral resource properties for potential acquisition.
- Acquires and explores mineral resource properties.
- Develops mineral resource properties.
- Acquires pharmaceutical and medical technology products.
- Develops pharmaceutical and medical technology products.
- Aims to commercialize acquired and developed products and services.
How Does NSRS Make Money?
- Acquire mineral resource properties with potential for development.
- Develop and potentially sell or license mineral resource assets.
- Acquire and develop pharmaceutical and medical technology products.
- Generate revenue through the sale of developed products and services.
What Industry Does NSRS Operate In?
North Springs Resources Corp. operates within the Drug Manufacturers - Specialty & Generic industry, a segment of the broader healthcare sector. This industry is characterized by intense competition, stringent regulatory requirements, and continuous innovation. Companies like AXRX, CHHL, DECN, NUNZ, and PRCNF represent the competitive landscape. The market is driven by factors such as an aging population, increasing prevalence of chronic diseases, and advancements in medical technology. North Springs Resources' ability to carve out a niche depends on its success in developing innovative products and navigating the complex regulatory environment.
Who Are NSRS's Key Customers?
- Potential customers for mineral resources include mining companies and industrial users.
- Potential customers for pharmaceutical products include healthcare providers and patients.
- Potential customers for medical technology products include hospitals and clinics.
Research confidence
Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.
- ● Scoring coverage unknown
- ● No usable price
- ● No filing on record
- ● No analyst coverage
Company Profile
North Springs Resources Corp. operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. It is headquartered in Riverview, US. The company is led by CEO John E. Vivian. NSRS has traded publicly since 2011.
Key Financial Metrics
Return on equity for North Springs Resources Corp. stands at 0.9%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -24.6%, showing how much profit it generates from its asset base. Its free cash flow yield is 11.6%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.01 means current liabilities exceed short-term assets, a liquidity point worth watching.
Financial Health
North Springs Resources Corp.'s Piotroski F-Score is 0/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of -1.30 places it in the distress zone, a signal of elevated financial risk.
NSRS Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
NSRS Latest News
No recent news available for NSRS.
NSRS Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for NSRS.
Price Targets
Wall Street price target analysis for NSRS.
NSRS MoonshotScore
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for NSRS; grades run from A+ (80-100) to F (below 30).
Leadership: John E. Vivian
CEO
Information on John E. Vivian's background is limited. Without further data, it's difficult to provide a comprehensive biography. Further research into his career history, education, and previous roles would be needed to assess his qualifications for leading North Springs Resources Corp.
Track Record: Due to the limited information available, John E. Vivian's track record at North Springs Resources Corp. or previous companies cannot be accurately assessed. Key achievements, strategic decisions, and company milestones under his leadership are currently unknown. Further research is needed to evaluate his performance and contributions.
NSRS OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that North Springs Resources Corp. may not meet the minimum financial standards or disclosure requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may have limited or no financial reporting, making it difficult for investors to assess their financial health and operational performance. Trading on the OTC Other tier is generally associated with higher risk and greater potential for fraud compared to companies listed on major exchanges like the NYSE or NASDAQ, which have stricter listing standards and regulatory oversight.
- OTC Tier: OTC Other
- Limited financial disclosure increases the risk of investing due to lack of transparency.
- Low trading volume and wide bid-ask spread can make it difficult to buy or sell shares.
- Higher potential for fraud and manipulation compared to listed exchanges.
- OTC Other tier listing indicates the company may not meet minimum financial standards.
- Limited analyst coverage and investor interest.
- Verify the company's financial statements, if available.
- Research the background and experience of the management team.
- Assess the company's business model and competitive landscape.
- Understand the risks associated with investing in OTC stocks.
- Consult with a financial advisor before investing.
- Check for any regulatory actions or legal issues involving the company.
- Determine the company's revenue sources and sustainability.
- Company has been in operation since 2009.
- Company has a physical headquarters in Riverview, Florida.
- Company has a CEO (John E. Vivian).
NSRS Healthcare Stock FAQ
What do analysts say about NSRS stock?
Due to its OTC listing and small market capitalization, North Springs Resources Corp. (NSRS) likely has limited or no analyst coverage. This lack of coverage means there are no readily available analyst ratings, price targets, or consensus estimates for the stock. Investors must rely on their own research and due diligence to assess the company's value and potential.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
MoonshotScore is not published for this security.
Data provided for informational purposes only.
- Limited information available on North Springs Resources Corp., particularly regarding its financial performance and specific projects.
- OTC stocks carry higher risk due to lower liquidity and regulatory oversight.